Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Torulopsis candida, a new opportunistic pathogen.

G St-Germain, M Laverdière

    Journal of Clinical Microbiology
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial.

    Transplant infectious disease : an official journal of the Transplantation Society·2015
    Same author

    Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.

    Antimicrobial agents and chemotherapy·2014
    Same author

    Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.

    Antimicrobial agents and chemotherapy·2013
    Same author

    Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

    Antimicrobial agents and chemotherapy·2013
    Same author

    Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

    Antimicrobial agents and chemotherapy·2012
    Same author

    Endemic human blastomycosis in Quebec, Canada, 1988-2011.

    Epidemiology and infection·2012

    This study reports the first case of fungemia caused by Torulopsis candida (Candida famata) linked to intravenous catheters in a bone marrow transplant patient. Prompt treatment involving catheter removal and antifungal medication led to successful recovery.

    Area of Science:

    • Medical Mycology
    • Infectious Diseases
    • Hematology

    Background:

    • Intravenous catheter use is common in immunocompromised patients.
    • Fungal infections pose a significant risk in bone marrow transplant recipients.
    • Torulopsis candida (Candida famata) is an opportunistic yeast pathogen.

    Observation:

    • A bone marrow transplant patient developed fungemia.
    • The yeast Torulopsis candida (Candida famata) was isolated from blood cultures and an intravenous catheter.
    • The patient had an compromised immunological status.

    Findings:

    • This is the first documented case of intravenous-catheter-associated fungemia caused by Torulopsis candida (Candida famata).
    • Both the intravenous catheter and the patient's immune status were identified as predisposing factors.

    Related Experiment Videos

  • The infection was successfully treated with catheter removal and amphotericin B.

    • Implications:

    • Highlights the risk of Torulopsis candida (Candida famata) fungemia in immunocompromised patients with central venous catheters.
    • Emphasizes the importance of catheter care and prompt diagnosis in preventing and managing invasive fungal infections.
    • Suggests amphotericin B as an effective treatment for this specific type of fungemia.